Table 3.
Time to virologic suppression in study RSA and historical non-RSA control
| Outcomes | Study RSA n = 43 |
Non-RSA Control n = 42 |
P value |
|---|---|---|---|
| Diagnosis to viral load < 200 copies/mL, median (IQR) | 21.0 (11.0–31.0) days | 112 (81.5–196.0) days | < 0.001 |
| ART to viral load < 200 copies/mL, median (IQR) | 16.0 (9.0–29.0) days | 34.5 (30.25–73.50) days | < 0.001 |
| Diagnosis to viral load < 50 copies/mL, median (IQR) | 32.0 (19.0–56.0) days* | 181.0 (110.5–279.8) days | < 0.001 |
| ART to viral load < 50 copies/mL, median (IQR) | 28.0 (13.0–56.0) days* | 62.0 (34.0–173.5) days | < 0.001 |
*n = 41